06.24.25 -- Overcoming Manufacturing Hurdles To Scale iPSC Therapies

Learn how site-specific fluorescent labeling addresses key challenges in flow cytometry-based evaluations by enhancing assay sensitivity, reducing variability, and ensuring reliable results.

Explore effective strategies and cleaning supplies to ensure irregular cleanroom surfaces, such as light switches, door handles, valves, and piping, maintain the same standards as more accessible areas.

Flow cytometry needs to be standardized and quantitative. Review the fundamental principles and best practices for instrument qualification and calibration, assay optimization, and method validation.

Alternatives to CRISPR-Cas9 address limitations like delivery challenges and off-target effects. Emerging nucleases offer improved specificity, smaller sizes, and therapeutic applications.

Explore a stepwise approach for integrating process intensification principles into an existing process to increase productivity, reduce costs, and improve process sustainability.

Discover how integrated solutions create a harmonious bioprocess ecosystem. Learn about data integration, digital technologies, and automation to streamline your lab workflow and drive innovation.

Develop an automated CAR-T cell therapy process with the help of an innovative platform, and learn strategies to optimize vein-to-vein time and enhance CAR-T cell shelf life.

Explore the performance of a serum-free medium designed for HEK-293 cells, comparing its efficacy to traditional media for protein expression and cell proliferation.

The emergence of RNA-encapsulated-lipid nanoparticles has introduced a seismic shift in biopharma innovation. But how will the industry adapt to diversifying applications and scales going forward?

Life science organizations are shifting to data-driven oversight. Discover how remote monitoring technologies are revolutionizing operational efficiency and innovation.

Delve into the intricacies of Impingement Jets Mixing (IJM) technology and its pivotal role in the scalable and reproducible production of Lipid Nanoparticles (LNPs) for drug delivery.

Learn about a partnership that will enable automated filling of cryovials within a closed and sterile environment, offering an enhanced DPI filling system for developers and CMOs.